08 Feb, 2022 CereVasc Receives FDA IDE Approval to Begin Initial Clinical Study of the eShunt® System for Patients with Normal Pressure Hydrocephalus Admin2023-11-06T21:21:09+00:00February 8th, 2022| Read More
07 Dec, 2021 CereVasc Announces Publication of First-in-Human Case Report of its eShunt System for the Treatment of Communicating Hydrocephalus Admin2023-11-06T21:13:31+00:00December 7th, 2021| Read More
10 Feb, 2021 First patient treated in CereVasc clinical trial of eShunt™ System for communicating hydrocephalus cerevasc2023-02-14T15:48:38+00:00February 10th, 2021| Read More
04 Nov, 2019 CereVasc, LLC Receives Approval to Initiate First-in-Human Clinical Study of the eShunt System cerevasc2023-02-14T15:48:39+00:00November 4th, 2019| Read More
25 Sep, 2017 Initial Results of the eShunt System Presented at the International Society of Hydrocephalus and Cerebrospinal Fluid Disorders Annual meeting in Kobe, Japan cerevasc2023-02-14T15:48:40+00:00September 25th, 2017| Read More
06 Aug, 2014 Tufts Medical Center and ATON Partners Announce Formation of CereVasc, LLC cerevasc2023-02-14T15:48:41+00:00August 6th, 2014| Read More
